Harry was just 2 years old when doctors diagnosed him with acute myeloid leukemia, a cancer of the blood and bone marrow. Now 6, the Charlotte boy has endured chemotherapy, a stem cell transplant that failed after 100 days, and a second transplant from a half-matched donor before reaching remission — and this fall, his family is preparing to tell that story publicly at Charlotte's St. Jude Walk.
According to WSOC-TV, Harry has three siblings and stayed at St. Jude Children's Research Hospital in Memphis for treatment. His first stem cell transplant failed after 100 days, but a second transplant from his half-match donor, a woman named Erica, ultimately took. Erica has called serving as Harry's donor a life-altering experience and has urged the public to support families affected by childhood cancer with something as simple as a text message or phone call.
A Complex Cancer With Tougher Odds
Harry's diagnosis falls into a subtype of pediatric cancer with a steeper road to recovery. Acute myeloid leukemia represents roughly 20% of childhood leukemia cases and carries a 5-year survival rate of 65% to 70%, compared with acute lymphoblastic leukemia, which makes up 75% of cases and has a survival rate exceeding 90%, according to the Children's Cancer Research Fund. AML affects bone marrow myeloid cells and frequently requires a stem cell transplant.
When Harry's first transplant failed, doctors turned to a haploidentical transplant, using Erica as a half-matched relative donor combined with specialized immune-cell depletion strategies to prevent organ rejection, a technique detailed by the National Institutes of Health. The approach means virtually every child needing an urgent transplant can find a donor, even without a full match.
Ongoing Fight Against a Transplant Complication
Though Harry is now in remission, he continues to battle graft-versus-host disease, a complication of his transplant that impacts some of his organs and skin, per the same WSOC-TV report. To manage it, he receives light therapy once a week, and his family travels to St. Jude in Memphis once a month to manage the effects of his transplant.
That weekly light therapy is almost certainly extracorporeal photopheresis, an advanced nonsurgical treatment for steroid-refractory graft-versus-host disease that removes white blood cells, treats them with a photoactive drug and ultraviolet light to suppress aggressive immune cells, and reinfuses them into the body, according to the Children's Hospital of Philadelphia. Graft-versus-host disease occurs when donor immune cells attack the recipient's skin and organs.
Family Celebrates Small Milestones
Despite the ongoing challenges, Harry's family recently went camping for the first time, and his parents hope he'll soon start first grade — milestones they say represent a shot at normalcy that once seemed uncertain. Harry's father described his son as the life of the party and the strongest kid they know, adding that Harry would not be alive without the Memphis team and St. Jude, per WSOC-TV's report.
St. Jude Children's Research Hospital covers all medical treatment, travel, housing, and food for patient families at zero out-of-pocket cost, billing private insurance if available without requiring copays or deductibles, according to St. Jude Children's Research Hospital. The hospital raises approximately 89% of its annual operating funds through philanthropic donations, which explains why local fundraising walks like Charlotte's remain essential to its mission.
Charlotte's St. Jude Walk Details
Harry's family plans to speak at the Charlotte St. Jude Walk on October 10 at First Ward Park in Uptown Charlotte. The event opens at 8:30 a.m., with a 9:40 a.m. opening ceremony where Harry's family will address the crowd, followed by the walk itself at 10:00 a.m. Deneige Broom will emcee the Charlotte event.
Charlotte's gathering is part of a much larger movement. The St. Jude Walk is a nationwide series spanning more than 30 U.S. cities alongside virtual events every autumn during Childhood Cancer Awareness Month and October, featuring patient stories and community participation. Thousands recently turned out for a similar event in Memphis, where organizers chased a $900,000 fundraising goal, as Hoodline reported in its coverage of the Memphis walk.
Local Clinical Access in the Carolinas
Families like Harry's in the Charlotte region also benefit from direct clinical ties to St. Jude close to home. The St. Jude Affiliate Clinic at Novant Health Hemby Children's Hospital is the only St. Jude affiliate clinic in the Carolinas, allowing regional pediatric patients to receive St. Jude clinical trials and specialized protocols without traveling far from home, according to Novant Health.
A Broader Public Health Picture
September marks Childhood Cancer Awareness Month, and cancer remains the leading cause of death by disease among U.S. children after infancy, with approximately 15,000 children and adolescents diagnosed with cancer nationwide each year, according to the Alex's Lemonade Stand Foundation. Survival has improved dramatically since St. Jude opened in 1962, when overall 5-year survival rates for U.S. children with cancer were under 20%; today, that figure exceeds 80%, driven by clinical research the hospital shares freely with hospitals worldwide.
Even after remission, survivors like Harry face a long road of monitoring. Public health studies indicate that by age 45, up to 95% of childhood cancer survivors develop a serious chronic health condition, and by age 30 their risk of a severe or life-threatening illness is seven times higher than that of their siblings, largely due to treatment side effects from chemotherapy and bone marrow transplants. For Harry's family, that reality means continued monthly trips to Memphis and weekly light therapy sessions even as they celebrate ordinary moments like a first camping trip and, they hope, a first day of first grade.
